List of Excipients in API octreotide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing octreotide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Chiesi USA Inc | MYCAPSSA | octreotide | 10122-550 | AMMONIA | |
| Chiesi USA Inc | MYCAPSSA | octreotide | 10122-550 | FERROSOFERRIC OXIDE | |
| Chiesi USA Inc | MYCAPSSA | octreotide | 10122-550 | GELATIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing octreotide
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 | LACTIC ACID, L- |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 | SODIUM CHLORIDE |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 | SODIUM HYDROXIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for octreotide
Excipient focus: ACETIC ACID
octreotide drug variants containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | octreotide acetate | 23155-685 |
| Sagent Pharmaceuticals | octreotide acetate | 25021-451 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
octreotide drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
octreotide drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
octreotide drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOCAPRYLATE
octreotide drug variants containing GLYCERYL MONOCAPRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing GLYCERYL MONOCAPRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTIC ACID
octreotide drug variants containing LACTIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Sun Pharmaceutical Industries Inc | octreotide acetate | 62756-452 |
| Gland Pharma Limited | octreotide acetate | 68083-515 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing LACTIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTIC ACID, L-
octreotide drug variants containing LACTIC ACID, L-
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Hainan Shuangcheng Pharmaceuticals Co Ltd | octreotide acetate | 52958-046 |
| Mylan Institutional LLC | octreotide acetate | 67457-239 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing LACTIC ACID, L-
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM CHLORIDE
octreotide drug variants containing MAGNESIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing MAGNESIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
octreotide drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| Hainan Shuangcheng Pharmaceuticals Co Ltd | octreotide acetate | 52958-046 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
octreotide drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: PHENOL
octreotide drug variants containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | octreotide acetate | 23155-685 |
| Sun Pharmaceutical Industries Inc | octreotide acetate | 62756-452 |
| Gland Pharma Limited | octreotide acetate | 68083-515 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
octreotide drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K12
octreotide drug variants containing POVIDONE K12
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing POVIDONE K12
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
octreotide drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
octreotide drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
octreotide drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
octreotide drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | octreotide acetate | 23155-685 |
| Sagent Pharmaceuticals | octreotide acetate | 25021-451 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
octreotide drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | octreotide acetate | 23155-685 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CAPRYLATE
octreotide drug variants containing SODIUM CAPRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM CAPRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
octreotide drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | octreotide acetate | 23155-685 |
| Sagent Pharmaceuticals | octreotide acetate | 25021-451 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
octreotide drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Mylan Institutional LLC | octreotide acetate | 67457-239 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
octreotide drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
octreotide drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
octreotide drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRICAPRILIN
octreotide drug variants containing TRICAPRILIN
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing TRICAPRILIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
octreotide drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
octreotide drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | octreotide acetate | 0078-0180 |
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Teva Parenteral Medicines Inc | octreotide acetate | 0703-3301 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| Fresenius Kabi USA LLC | octreotide acetate | 63323-365 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
